HemaCare Corporation today announced that John Doumitt, age 44, currently the Company's General Manager, Transfusable Products, has been named Chief Executive Officer and been appointed to the Company's Board of Directors. He will also continue as General Manager, Transfusable Products.
Julian Steffenhagen, age 65, who has been serving as Interim Chief Executive Officer, will continue as Chairman of the Board of Directors.
Mr. Doumitt joined HemaCare in October of 2007 and has successfully overseen the revitalization of the Company's Transfusable Products business. His healthcare background includes management positions at Activus Healthcare Solutions, Cardinal Health Nuclear Pharmacy Services and Syncor International. John holds a BS in Industrial Engineering from the University of Southern California, a Masters in Management from Purdue University and is a registered Professional Engineer.
Bob Chilton, age 50, HemaCare's Chief Financial Officer, Corporate Secretary and General Manager, Therapeutic Services, has also been appointed to the Company's Board of Directors. Mr. Chilton joined HemaCare in October of 2003 as CFO and has been the driver of several key initiatives since that time, including the transition to all volunteer donors, closure of the HemaCare BioScience subsidiary and consolidation of Southern California activities in the new Van Nuys location. Recently he also assumed operating responsibility for the Company's Therapeutic Services business. Mr. Chilton holds a BS in Economics and an MBA from University of California, Los Angeles, and previously worked with KPMG Peat Marwick. He is also a Certified Public Accountant.
Chairman Julian Steffenhagen commented, "HemaCare is very fortunate to have individuals the caliber of John Doumitt and Bob Chilton available to lead our management team and participate with our four outside directors in overseeing Company affairs and defining strategic direction. They understand the healthcare environment and the blood products and services marketplace. We look forward to their continued success."
About HemaCare Corporation
Founded in 1978, HemaCare is a provider of blood products and services to the healthcare industry in the U.S. HemaCare is licensed by the FDA and accredited by the AABB. The Company focuses on providing cost effective, high quality solutions to organizations with a need for blood-related products and services.
Contact:
HemaCare Corporation
Robert S. Chilton
Executive Vice President and Chief Financial Officer
877-310-0717
http://www.hemacare.com
Source: HemaCare Corporation
Julian Steffenhagen, age 65, who has been serving as Interim Chief Executive Officer, will continue as Chairman of the Board of Directors.
Mr. Doumitt joined HemaCare in October of 2007 and has successfully overseen the revitalization of the Company's Transfusable Products business. His healthcare background includes management positions at Activus Healthcare Solutions, Cardinal Health Nuclear Pharmacy Services and Syncor International. John holds a BS in Industrial Engineering from the University of Southern California, a Masters in Management from Purdue University and is a registered Professional Engineer.
Bob Chilton, age 50, HemaCare's Chief Financial Officer, Corporate Secretary and General Manager, Therapeutic Services, has also been appointed to the Company's Board of Directors. Mr. Chilton joined HemaCare in October of 2003 as CFO and has been the driver of several key initiatives since that time, including the transition to all volunteer donors, closure of the HemaCare BioScience subsidiary and consolidation of Southern California activities in the new Van Nuys location. Recently he also assumed operating responsibility for the Company's Therapeutic Services business. Mr. Chilton holds a BS in Economics and an MBA from University of California, Los Angeles, and previously worked with KPMG Peat Marwick. He is also a Certified Public Accountant.
Chairman Julian Steffenhagen commented, "HemaCare is very fortunate to have individuals the caliber of John Doumitt and Bob Chilton available to lead our management team and participate with our four outside directors in overseeing Company affairs and defining strategic direction. They understand the healthcare environment and the blood products and services marketplace. We look forward to their continued success."
About HemaCare Corporation
Founded in 1978, HemaCare is a provider of blood products and services to the healthcare industry in the U.S. HemaCare is licensed by the FDA and accredited by the AABB. The Company focuses on providing cost effective, high quality solutions to organizations with a need for blood-related products and services.
Contact:
HemaCare Corporation
Robert S. Chilton
Executive Vice President and Chief Financial Officer
877-310-0717
http://www.hemacare.com
Source: HemaCare Corporation
0 comments:
Post a Comment